ANNMOX

This brand name is authorized in Nigeria.

Active ingredients

The drug ANNMOX contains one active pharmaceutical ingredient (API):

1	Amoxicillin trihydrate UNII 804826J2HU - AMOXICILLIN
	Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.
	Read more about Amoxicillin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-0329	Powder for suspension	Annmox Powder for Oral Suspension PWD_F_SOL 125 mg/5 mL 100 mL (in HDPE white bottle)	Powder for oral Suspension. A white powder filled in HDPE bottle which turns yellow suspension on reconstitution	21/12/2023
A11-0773	Suspension/Drops	Annmox Drops SUSP_DROPS 100 mg/mL 20 mL (in amber glass bottle)	Powder for oral Suspension. A white powder filled in a glass bottle which turns yellow on reconstitution, packed in a 20-mL Amber glass bottle	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CA04	Amoxicillin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CA Penicillins with extended spectrum
Discover more medicines within J01CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-0329, A11-0773